Open AccessIntegrating and Interpreting Findings from the Latest Treatment as Prevention Trials
Author(s) -
Marie A Brault,
Donna Spiegelman,
Salim Safurdeen. Abdool Karim,
Sten H. Vermund
Publication year - 2020
Publication title -
current hiv/aids reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.135
H-Index - 56
eISSN - 1548-3576
pISSN - 1548-3568
DOI - 10.1007/s11904-020-00492-4
Subject(s) - human immunodeficiency virus (hiv) , linkage (software) , incidence (geometry) , treatment as prevention , medicine , intervention (counseling) , environmental health , family medicine , antiretroviral therapy , psychiatry , biology , viral load , biochemistry , physics , gene , optics
In 2018-2019, studies were published assessing the effectiveness of reducing HIV incidence by expanding HIV testing, linkage to HIV treatment, and assistance to persons living with HIV to adhere to their medications (the "90-90-90" strategy). These tests of "treatment as prevention" (TasP) had complex results.